|
Fruchtman, S M; Mack, K; Kaplan, M E et al. (1997) From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera. Semin Hematol 34:17-23
|
|
Wanless, I R; Peterson, P; Das, A et al. (1990) Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. Hepatology 12:1166-74
|
|
Swolin, B; Weinfeld, A; Westin, J (1988) A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 72:386-95
|
|
Stoll, D B; Peterson, P; Exten, R et al. (1988) Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome. Am J Hematol 27:77-83
|
|
Iland, H J; Laszlo, J; Case Jr, D C et al. (1987) Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis. Am J Hematol 25:191-201
|
|
Kaplan, M E; Mack, K; Goldberg, J D et al. (1986) Long-term management of polycythemia vera with hydroxyurea: a progress report. Semin Hematol 23:167-71
|
|
Murphy, S; Iland, H; Rosenthal, D et al. (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 23:177-82
|
|
Berk, P D; Goldberg, J D; Donovan, P B et al. (1986) Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol 23:132-43
|
|
Wasserman, L R (1986) Polycythemia Vera Study Group: a historical perspective. Semin Hematol 23:183-7
|
|
Ellis, J T; Peterson, P; Geller, S A et al. (1986) Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin Hematol 23:144-55
|
Showing the most recent 10 out of 11 publications
